Our 30-bed phase I unit is the only one in the Caribbean and one of the few in South America. Our phase I unit has state-of-the-art monitoring technology that includes remote telemetry and sophisticated software designed to manage phase I trials.

Fundación de Investigación has conducted trials with confinement duration of up to 16 days, including multiple intensive pharmacokinetic and pharmacodynamic trials as SAD and MAD for many molecules. We also conduct hepatic impairment and drug-to-drug interaction studies. We have a database of normal volunteers and the capability to conduct all kinds of early studies in both normal volunteers and patients. Our phase I unit’s experienced staff and facilities allow the trials to be conducted without interruption 7 days a week.